AAAAAA

   
Results: 1-17 |
Results: 17
THE EFFECT OF SODIUM MONOFLUOROPHOSPHATE PLUS CALCIUM ON VERTEBRAL FRACTURE RATE IN POSTMENOPAUSAL WOMEN WITH MODERATE OSTEOPOROSIS - A RANDOMIZED, CONTROLLED TRIAL
Authors: REGINSTER JY MEURMANS L ZEGELS B ROVATI LC MINNE HW GIACOVELLI G TAQUET AN SETNIKAR I COLLETTE J GOSSET C
Citation: Jy. Reginster et al., THE EFFECT OF SODIUM MONOFLUOROPHOSPHATE PLUS CALCIUM ON VERTEBRAL FRACTURE RATE IN POSTMENOPAUSAL WOMEN WITH MODERATE OSTEOPOROSIS - A RANDOMIZED, CONTROLLED TRIAL, Annals of internal medicine, 129(1), 1998, pp. 1
A 2-YEAR PHASE-II STUDY WITH 1-YEAR OF FOLLOW-UP OF RISEDRONATE (NE-58095) IN POSTMENOPAUSAL OSTEOPOROSIS
Authors: CLEMMESEN B RAVN P ZEGELS B TAQUET AN CHRISTIANSEN C REGINSTER JY
Citation: B. Clemmesen et al., A 2-YEAR PHASE-II STUDY WITH 1-YEAR OF FOLLOW-UP OF RISEDRONATE (NE-58095) IN POSTMENOPAUSAL OSTEOPOROSIS, Osteoporosis international, 7(5), 1997, pp. 488-495
PARATHYROID-HORMONE IN THE TREATMENT OF INVOLUTIONAL OSTEOPOROSIS - BACK TO THE FUTURE
Authors: REGINSTER JY TAQUET AN FRAIKIN G GOSSET C ZEGELS B
Citation: Jy. Reginster et al., PARATHYROID-HORMONE IN THE TREATMENT OF INVOLUTIONAL OSTEOPOROSIS - BACK TO THE FUTURE, Osteoporosis international, 7, 1997, pp. 163-168
SODIUM MONOFLUOROPHOSPHATE REDUCES VERTEBRAL FRACTURES IN MODERATE POSTMENOPAUSAL OSTEOPOROSIS
Authors: REGINSTER JY MEURMANS L ZEGELS B ROVATI LC MINNE HW GIACOVELLI G TAQUET AN SETNIKAR I COLLETTE J
Citation: Jy. Reginster et al., SODIUM MONOFLUOROPHOSPHATE REDUCES VERTEBRAL FRACTURES IN MODERATE POSTMENOPAUSAL OSTEOPOROSIS, Journal of bone and mineral research, 12, 1997, pp. 7-7
DIAGNOSTIC EFFICIENCY OF A SELF-EVALUATING RISK ASSESSMENT FOR POSTMENOPAUSAL OSTEOPOROSIS
Authors: GOEMAERE S ZEGELS B TOYE K CREMER S DEMUYNCK R VANHEUSDEN E ALBERT A DEWE W KAUFMAN JM REGINSTER JY
Citation: S. Goemaere et al., DIAGNOSTIC EFFICIENCY OF A SELF-EVALUATING RISK ASSESSMENT FOR POSTMENOPAUSAL OSTEOPOROSIS, Journal of bone and mineral research, 12, 1997, pp. 570-570
PREDICTION OF BONE LOSS RATE IN HEALTHY POSTMENOPAUSAL WOMEN
Authors: REGINSTER JY DEROISY R COLLETTE J ALBERT A ZEGELS B
Citation: Jy. Reginster et al., PREDICTION OF BONE LOSS RATE IN HEALTHY POSTMENOPAUSAL WOMEN, Calcified tissue international, 60(3), 1997, pp. 261-264
EFFECT OF RISEDRONATE ON COLLAGEN CROSS-LINKS IN POSTMENOPAUSAL OSTEOPOROSIS
Authors: ZEGELS B BALENA R EASTELL R RUSSELL RGG PACK SE REGINSTER JY
Citation: B. Zegels et al., EFFECT OF RISEDRONATE ON COLLAGEN CROSS-LINKS IN POSTMENOPAUSAL OSTEOPOROSIS, Journal of bone and mineral research, 10, 1995, pp. 455-455
FEMORAL BONE-DENSITY AND VITAMIN-D DEFICIENCY IN ELDERLY WOMEN
Authors: DEROISY R PIRENNE H FREDERICK I ZEGELS B TAQUET AN NOEL V ZHENG ZX REGINSTER JY
Citation: R. Deroisy et al., FEMORAL BONE-DENSITY AND VITAMIN-D DEFICIENCY IN ELDERLY WOMEN, Journal of bone and mineral research, 10, 1995, pp. 463-463
LONG-TERM PERFORMANCE IN-VITRO AND IN-VIVO OF DUAL-ENERGY X-RAY ABSORPTIOMETRY
Authors: REGINSTER JY DEROISY R ZEGELS B JUPSIN I ALBERT A FRANCHIMONT P
Citation: Jy. Reginster et al., LONG-TERM PERFORMANCE IN-VITRO AND IN-VIVO OF DUAL-ENERGY X-RAY ABSORPTIOMETRY, Clinical rheumatology, 14(2), 1995, pp. 180-186
BONE-MINERAL DENSITY OF THE SPINE AND THE HIP MEASURED WITH DUAL-ENERGY X-RAY ABSORPTIOMETRY - NORMAL RANGE AND FRACTURE THRESHOLD FOR WESTERN-EUROPEAN (BELGIAN) POSTMENOPAUSAL FEMALES
Authors: REGINSTER JY JANSSEN C DEROISY R ZEGELS B ALBERT A FRANCHIMONT P
Citation: Jy. Reginster et al., BONE-MINERAL DENSITY OF THE SPINE AND THE HIP MEASURED WITH DUAL-ENERGY X-RAY ABSORPTIOMETRY - NORMAL RANGE AND FRACTURE THRESHOLD FOR WESTERN-EUROPEAN (BELGIAN) POSTMENOPAUSAL FEMALES, Clinical rheumatology, 14(1), 1995, pp. 68-75
A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF INTERMITTENT NASAL SALMON-CALCITONIN FOR PREVENTION OF POSTMENOPAUSAL LUMBAR SPINE BONE LOSS
Authors: REGINSTER JY DEROISY R LECART MP SARLET N ZEGELS B JUPSIN I DELONGUEVILLE M FRANCHIMONT P
Citation: Jy. Reginster et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF INTERMITTENT NASAL SALMON-CALCITONIN FOR PREVENTION OF POSTMENOPAUSAL LUMBAR SPINE BONE LOSS, The American journal of medicine, 98(5), 1995, pp. 452-458
LONG-TERM (3 YEARS) PREVENTION OF TRABECULAR POSTMENOPAUSAL BONE LOSSWITH LOW-DOSE INTERMITTENT NASAL SALMON-CALCITONIN
Authors: REGINSTER JY DENIS D DEROISY R LECART MP DELONGUEVILLE M ZEGELS B SARLET N NOIRFALISSE P FRANCHIMONT P
Citation: Jy. Reginster et al., LONG-TERM (3 YEARS) PREVENTION OF TRABECULAR POSTMENOPAUSAL BONE LOSSWITH LOW-DOSE INTERMITTENT NASAL SALMON-CALCITONIN, Journal of bone and mineral research, 9(1), 1994, pp. 69-73
PREVENTION OF OSTEOPOROSIS WITH NASAL SALMON-CALCITONIN - EFFECT OF ANTI-SALMON CALCITONIN ANTIBODY-FORMATION
Authors: REGINSTER JY GASPAR S DEROISY R ZEGELS B FRANCHIMONT P
Citation: Jy. Reginster et al., PREVENTION OF OSTEOPOROSIS WITH NASAL SALMON-CALCITONIN - EFFECT OF ANTI-SALMON CALCITONIN ANTIBODY-FORMATION, Osteoporosis international, 3(5), 1993, pp. 261-264
ACUTE BIOCHEMICAL VARIATIONS INDUCED BY 4 DIFFERENT CALCIUM SALTS IN HEALTHY MALE-VOLUNTEERS
Authors: REGINSTER JY DENIS D BARTSCH V DEROISY R ZEGELS B FRANCHIMONT P
Citation: Jy. Reginster et al., ACUTE BIOCHEMICAL VARIATIONS INDUCED BY 4 DIFFERENT CALCIUM SALTS IN HEALTHY MALE-VOLUNTEERS, Osteoporosis international, 3(5), 1993, pp. 271-275
NEW RADIOIMMUNOASSAY FOR DETERMINATION OF BONE SPECIFIC ISOENZYMES OFSERUM ALKALINE-PHOSPHATASES ACTIVITY (OSTASE-DEGREES) - VALIDATION AND CLINICAL PERSPECTIVE
Authors: REGINSTER JY MEURMANS L ZEGELS B DARTE C COLLETTE J DEROISY R FRANCHIMONT P
Citation: Jy. Reginster et al., NEW RADIOIMMUNOASSAY FOR DETERMINATION OF BONE SPECIFIC ISOENZYMES OFSERUM ALKALINE-PHOSPHATASES ACTIVITY (OSTASE-DEGREES) - VALIDATION AND CLINICAL PERSPECTIVE, Journal of bone and mineral research, 8, 1993, pp. 190000261-190000261
EVIDENCE THAT TILUDRONATE IS AN INTERESTING PERSPECTIVE FOR PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
Authors: REGINSTER JY ETHGEN D BARBIER A GEUSENS P LECART MP CHAPPARD D DEVERNEJOUL MC ZEGELS B FRANCHIMONT P
Citation: Jy. Reginster et al., EVIDENCE THAT TILUDRONATE IS AN INTERESTING PERSPECTIVE FOR PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS, Journal of bone and mineral research, 8, 1993, pp. 190000326-190000326
NASAL SALMON-CALCITONIN FOR PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS - A DOSE-RANGING PLACEBO-CONTROLLED STUDY
Authors: REGINSTER JY DEROISY R LECART MP ZEGELS B SARLET N DELONGUEVILLE M ALBERT A FRANCHIMONT P
Citation: Jy. Reginster et al., NASAL SALMON-CALCITONIN FOR PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS - A DOSE-RANGING PLACEBO-CONTROLLED STUDY, Journal of bone and mineral research, 8, 1993, pp. 190000340-190000340
Risultati: 1-17 |